Fingerprint
Dive into the research topics of 'Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically